Aurobindo Pharma Gets US FDA Inspection Report For Pashamylaram Unit
![](https://healthwire.co/wp-content/uploads/2020/02/images-2020-02-20T101522.338.jpeg)
New Delhi: Leading drug firm Aurobindo Pharma on Wednesday said it has got an establishment inspection report from the US health regulator with voluntary action indicated (VAI) status for its…
Share